Palliative Care
Showing 15 of 15 topics
  A
- 
            Use structured conversations to complete POLST or similar medical orders reflecting code status, treatment intensity, and artificial nutrition preferences across settings.
C
- 
            Use opioids with adjuvants such as corticosteroids and NSAIDs when appropriate; add bone targeted agents and consider palliative radiation or radionuclides for diffuse metastases.
- 
            Use scheduled long acting or frequent short acting opioids with breakthrough doses at 10 to 15 percent of the total daily dose, reassessing frequently and managing side effects.
- 
            Plan extubation for comfort by aligning goals, optimizing symptom control with opioids and anxiolytics, and preparing families for the process and expected changes.
- 
            Prevent opioid induced constipation with scheduled osmotic plus stimulant agents, adequate fluids when appropriate, and rescue measures for impaction.
D
- 
            Treat distressing breathlessness with low dose opioids, handheld fan or airflow to the face, positioning, and targeted oxygen only when hypoxemic.
H
- 
            Discuss hospice when life expectancy is about six months or less if the illness runs its usual course; focus on comfort, support services, and avoidance of burdensome care.
- 
            Treat symptomatic hypercalcemia with IV fluids, calcitonin for rapid effect, and a bisphosphonate or denosumab while aligning interventions to goals and prognosis.
M
- 
            Use opioids and antiemetics, antisecretory therapy such as octreotide, corticosteroids for edema, and venting gastrostomy when goals are comfort focused.
N
- 
            Use adjuvant agents for neuropathic pain with slow titration and monitoring for sedation and dizziness; combine with opioids only when needed.
- 
            Explain cause to families, minimize fluid burden and suction only gently in the oropharynx, and use anticholinergics such as glycopyrrolate or scopolamine when secretions are distressing.
O
- 
            Watch for myoclonus, hyperalgesia, hallucinations, or confusion; reduce dose, rotate opioid, hydrate if appropriate, and treat contributing factors.
- 
            When switching opioids, calculate equianalgesic dose, reduce for incomplete cross tolerance by 25 to 50 percent, and retitrate to effect with close monitoring.
P
- 
            For refractory symptoms at end of life, use proportionate sedation after interdisciplinary review and informed consent, with clear documentation of goals and monitoring.
T
- 
            Identify reversible contributors, provide calm environment with family presence, and use haloperidol or alternative antipsychotics for distressing agitation after safety measures.
    No topics match your filters.